908 Devices Inc (MASS)
5.63
-0.02
(-0.35%)
USD |
NASDAQ |
May 06, 16:00
908 Devices Cash from Financing (Quarterly): -1.295M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -1.295M |
December 31, 2023 | 0.095M |
September 30, 2023 | -0.248M |
June 30, 2023 | -0.401M |
March 31, 2023 | -15.38M |
December 31, 2022 | 0.411M |
September 30, 2022 | 0.171M |
June 30, 2022 | 0.467M |
March 31, 2022 | 0.13M |
Date | Value |
---|---|
December 31, 2021 | 94.53M |
September 30, 2021 | 0.483M |
June 30, 2021 | 0.276M |
March 31, 2021 | -0.566M |
December 31, 2020 | 137.18M |
September 30, 2020 | 0.005M |
June 30, 2020 | 0.001M |
March 31, 2020 | 0.003M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-15.38M
Minimum
Mar 2023
137.18M
Maximum
Dec 2020
12.70M
Average
0.095M
Median
Dec 2023
Cash from Financing (Quarterly) Benchmarks
Perspective Therapeutics Inc | 0.352M |
Retractable Technologies Inc | -0.1364M |
Xtant Medical Holdings Inc | 0.325M |
Asensus Surgical Inc | 0.172M |
Catheter Precision Inc | -0.107M |
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -9.357M |
Cash from Investing (Quarterly) | -5.78M |
Free Cash Flow | -25.53M |
Free Cash Flow Per Share (Quarterly) | -0.3137 |
Free Cash Flow to Equity (Quarterly) | -10.26M |
Free Cash Flow to Firm (Quarterly) | -10.26M |
Free Cash Flow Yield | -13.99% |